Cytotoxic T Cells swarm by homotypic chemokine signalling

  1. Jorge Luis Galeano Niño
  2. Sophie V Pageon
  3. Szun S Tay
  4. Feyza Colakoglu
  5. Daryan Kempe
  6. Jack Hywood
  7. Jessica K Mazalo
  8. James Cremasco
  9. Matt A Govendir
  10. Laura F Dagley
  11. Kenneth Hsu
  12. Simone Rizzetto
  13. Jerzy Zieba
  14. Gregory Rice
  15. Victoria Prior
  16. Geraldine M O'Neill
  17. Richard J Williams
  18. David R Nisbet
  19. Belinda Kramer
  20. Andrew I Webb
  21. Fabio Luciani
  22. Mark N Read
  23. Maté Biro  Is a corresponding author
  1. EMBL Australia, Australia
  2. University of New South Wales, Australia
  3. The University of Sydney, Australia
  4. The Walter and Eliza Hall Institute of Medical Research, Australia
  5. The Children's Hospital at Westmead, Australia
  6. University of Waterloo, Canada
  7. Kids Research, Australia
  8. Deakin University, Australia
  9. Australian National University, Australia
  10. University of Sydney, Australia

Abstract

Cytotoxic T lymphocytes (CTLs) are thought to arrive at target sites either via random search or following signals by other leukocytes. Here, we reveal independent emergent behaviour in CTL populations attacking tumour masses. Primary murine CTLs coordinate their migration in a process reminiscent of the swarming observed in neutrophils. CTLs engaging cognate targets accelerate the recruitment of distant T cells through long-range homotypic signalling, in part mediated via the diffusion of chemokines CCL3 and CCL4. Newly arriving CTLs augment the chemotactic signal, further accelerating mass recruitment in a positive feedback loop. Activated effector human T cells and chimeric antigen receptor (CAR) T cells similarly employ intra-population signalling to drive rapid convergence. Thus, CTLs recognising a cognate target can induce a localised mass response by amplifying the direct recruitment of additional T cells independently of other leukocytes.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files with extensive statistical information have been provided for all figures containing bar, box or violin plots. Complete transcriptomics and secretomics data are available in Supplementary Files 1 and 2 respectively. Custom code and notes are available at http://www.matebiro.com/software/motilisim

Article and author information

Author details

  1. Jorge Luis Galeano Niño

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Sophie V Pageon

    Medicine, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1701-5551
  3. Szun S Tay

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0186-8154
  4. Feyza Colakoglu

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Daryan Kempe

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Jack Hywood

    Sydney Medical School, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Jessica K Mazalo

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. James Cremasco

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Matt A Govendir

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Laura F Dagley

    Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4171-3712
  11. Kenneth Hsu

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  12. Simone Rizzetto

    Medicine, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3881-8759
  13. Jerzy Zieba

    School of Medical Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  14. Gregory Rice

    Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Canada
    Competing interests
    The authors declare that no competing interests exist.
  15. Victoria Prior

    Children's Cancer Research Unit, Kids Research, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2285-5398
  16. Geraldine M O'Neill

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  17. Richard J Williams

    School of Medicine, Deakin University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  18. David R Nisbet

    Advanced Biomaterials Lab, Research School of Engineering, Australian National University, Canberra, Australia
    Competing interests
    The authors declare that no competing interests exist.
  19. Belinda Kramer

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  20. Andrew I Webb

    Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
  21. Fabio Luciani

    School of Medical Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  22. Mark N Read

    Charles Perkins Centre, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  23. Maté Biro

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    For correspondence
    m.biro@unsw.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5852-3726

Funding

National Sciences and Engineering Research Council Canada (RGPIN 50503-10477 and 50503-10476)

  • Gregory Rice

National Health and Medical Research Council (GNT1135687)

  • David R Nisbet

University of Sydney CoE in Advanced Food Enginomics

  • Mark N Read

EMBL Australia

  • Maté Biro

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal breeding and experimentation were conducted in accordance with New South Wales state and Australian federal laws and animal ethics protocols overseen and approved by the University of New South Wales Animal Care and Ethics Committee (ACEC) under protocols 16/83B and 19/133B.

Human subjects: Human peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors after informed consent and were used in experiments under a Human Research Ethics Committee (HREC) approved protocol (Sydney Children's Hospitals Network, LNR/13/SCHN/241).

Reviewing Editor

  1. Satyajit Rath, Indian Institute of Science Education and Research (IISER), India

Version history

  1. Received: March 2, 2020
  2. Accepted: September 27, 2020
  3. Accepted Manuscript published: October 13, 2020 (version 1)
  4. Accepted Manuscript updated: October 16, 2020 (version 2)
  5. Version of Record published: November 16, 2020 (version 3)

Copyright

© 2020, Galeano Niño et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,608
    Page views
  • 865
    Downloads
  • 35
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jorge Luis Galeano Niño
  2. Sophie V Pageon
  3. Szun S Tay
  4. Feyza Colakoglu
  5. Daryan Kempe
  6. Jack Hywood
  7. Jessica K Mazalo
  8. James Cremasco
  9. Matt A Govendir
  10. Laura F Dagley
  11. Kenneth Hsu
  12. Simone Rizzetto
  13. Jerzy Zieba
  14. Gregory Rice
  15. Victoria Prior
  16. Geraldine M O'Neill
  17. Richard J Williams
  18. David R Nisbet
  19. Belinda Kramer
  20. Andrew I Webb
  21. Fabio Luciani
  22. Mark N Read
  23. Maté Biro
(2020)
Cytotoxic T Cells swarm by homotypic chemokine signalling
eLife 9:e56554.
https://doi.org/10.7554/eLife.56554

Share this article

https://doi.org/10.7554/eLife.56554

Further reading

    1. Computational and Systems Biology
    2. Neuroscience
    David O'Reilly, Ioannis Delis
    Tools and Resources

    The muscle synergy is a guiding concept in motor control research that relies on the general notion of muscles ‘working together’ towards task performance. However, although the synergy concept has provided valuable insights into motor coordination, muscle interactions have not been fully characterised with respect to task performance. Here, we address this research gap by proposing a novel perspective to the muscle synergy that assigns specific functional roles to muscle couplings by characterising their task-relevance. Our novel perspective provides nuance to the muscle synergy concept, demonstrating how muscular interactions can ‘work together’ in different ways: (1) irrespective of the task at hand but also (2) redundantly or (3) complementarily towards common task-goals. To establish this perspective, we leverage information- and network-theory and dimensionality reduction methods to include discrete and continuous task parameters directly during muscle synergy extraction. Specifically, we introduce co-information as a measure of the task-relevance of muscle interactions and use it to categorise such interactions as task-irrelevant (present across tasks), redundant (shared task information), or synergistic (different task information). To demonstrate these types of interactions in real data, we firstly apply the framework in a simple way, revealing its added functional and physiological relevance with respect to current approaches. We then apply the framework to large-scale datasets and extract generalizable and scale-invariant representations consisting of subnetworks of synchronised muscle couplings and distinct temporal patterns. The representations effectively capture the functional interplay between task end-goals and biomechanical affordances and the concurrent processing of functionally similar and complementary task information. The proposed framework unifies the capabilities of current approaches in capturing distinct motor features while providing novel insights and research opportunities through a nuanced perspective to the muscle synergy.

    1. Computational and Systems Biology
    Ron Sender, Elad Noor ... Yuval Dor
    Research Article

    Cell-free DNA (cfDNA) tests use small amounts of DNA in the bloodstream as biomarkers. While it is thought that cfDNA is largely released by dying cells, the proportion of dying cells' DNA that reaches the bloodstream is unknown. Here, we integrate estimates of cellular turnover rates to calculate the expected amount of cfDNA. By comparing this to the actual amount of cell type-specific cfDNA, we estimate the proportion of DNA reaching plasma as cfDNA. We demonstrate that <10% of the DNA from dying cells is detectable in plasma, and the ratios of measured to expected cfDNA levels vary a thousand-fold among cell types, often reaching well below 0.1%. The analysis suggests that local clearance, presumably via phagocytosis, takes up most of the dying cells' DNA. Insights into the underlying mechanism may help to understand the physiological significance of cfDNA and improve the sensitivity of liquid biopsies.